JAMES B BREITMEYER Insider Trading $AMEV CytoCore, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JAMES B BREITMEYER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JAMES B BREITMEYER. JAMES B BREITMEYER is VP PHARMACEUTICAL OPERATIONS in CytoCore, Inc. ($AMEV) and Chief Executive Officer in Oncternal Therapeutics, Inc. ($GTXI) and President, CEO in GTX INC /DE/ ($GTXI) and Director in ZOGENIX, INC. ($ZGNX) and Director in OTONOMY, INC. ($OTIC).

JAMES B BREITMEYER in CytoCore, Inc.

Trading Symbol: AMEV
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of JAMES B BREITMEYER: VP PHARMACEUTICAL OPERATIONS
Holdings: 33,172 shares
Latest Transaction: Feb 11 2004

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JAMES B BREITMEYER in CytoCore, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMEV, ONCT, OTIC, ZGNX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 11 2004AMEVCytoCore, Inc.BREITMEYER JAMES BVP PHARMACEUTICAL O ...BuyJ1.744,9078,53833,17228.3 K to 33.2 K (+17.36 %)

Page:   1